<?xml version="1.0" encoding="ISO-8859-1"?>

<rdf:RDF
 xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
 xmlns="http://purl.org/rss/1.0/"
 xmlns:taxo="http://purl.org/rss/1.0/modules/taxonomy/"
 xmlns:dc="http://purl.org/dc/elements/1.1/"
 xmlns:syn="http://purl.org/rss/1.0/modules/syndication/"
 xmlns:prism="http://purl.org/rss/1.0/modules/prism/"
 xmlns:admin="http://webns.net/mvcb/"
>

<channel rdf:about="http://jpet.aspetjournals.org/">
<title>Most-Read Full-Text Articles</title>
<link>http://jpet.aspetjournals.org/</link>
<description>for Journal of Pharmacology and Experimental Therapeutics. Most-read rankings are recalculated at the beginning of the month based on usage of full-text and PDF views for the previous month.</description>
<prism:coverDisplayDate>2008-11-12</prism:coverDisplayDate>
<items>
 <rdf:Seq>
  <rdf:li rdf:resource="http://jpet.aspetjournals.org/cgi/content/short/286/3/1404?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://jpet.aspetjournals.org/cgi/content/short/309/2/484?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://jpet.aspetjournals.org/cgi/content/short/288/2/714?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://jpet.aspetjournals.org/cgi/content/short/jpet.107.132225v1?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://jpet.aspetjournals.org/cgi/content/short/298/3/865?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://jpet.aspetjournals.org/cgi/content/short/294/2/735?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://jpet.aspetjournals.org/cgi/content/short/314/2/883?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://jpet.aspetjournals.org/cgi/content/short/318/2/657?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://jpet.aspetjournals.org/cgi/content/short/320/1/323?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://jpet.aspetjournals.org/cgi/content/short/300/1/118?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://jpet.aspetjournals.org/cgi/content/short/315/3/971?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://jpet.aspetjournals.org/cgi/content/short/285/3/931?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://jpet.aspetjournals.org/cgi/content/short/jpet.108.144154v1?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://jpet.aspetjournals.org/cgi/content/short/320/1/1?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://jpet.aspetjournals.org/cgi/content/short/jpet.108.143628v1?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://jpet.aspetjournals.org/cgi/content/short/327/2/287-a?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://jpet.aspetjournals.org/cgi/content/short/jpet.108.140798v1?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://jpet.aspetjournals.org/cgi/content/short/jpet.108.142315v1?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://jpet.aspetjournals.org/cgi/content/short/303/3/889?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://jpet.aspetjournals.org/cgi/content/short/jpet.108.136580v1?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://jpet.aspetjournals.org/cgi/content/short/301/3/820?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://jpet.aspetjournals.org/cgi/content/short/323/1/265?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://jpet.aspetjournals.org/cgi/content/short/jpet.108.142703v1?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://jpet.aspetjournals.org/cgi/content/short/jpet.108.145102v1?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://jpet.aspetjournals.org/cgi/content/short/jpet.108.141853v1?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://jpet.aspetjournals.org/cgi/content/short/281/1/103?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://jpet.aspetjournals.org/cgi/content/short/327/2/287?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://jpet.aspetjournals.org/cgi/content/short/304/1/1?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://jpet.aspetjournals.org/cgi/content/short/313/3/1217?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://jpet.aspetjournals.org/cgi/content/short/jpet.108.139006v1?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://jpet.aspetjournals.org/cgi/content/short/jpet.108.145219v1?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://jpet.aspetjournals.org/cgi/content/short/jpet.108.143578v1?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://jpet.aspetjournals.org/cgi/content/short/jpet.108.143883v1?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://jpet.aspetjournals.org/cgi/content/short/319/3/998?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://jpet.aspetjournals.org/cgi/content/short/jpet.108.145581v1?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://jpet.aspetjournals.org/cgi/content/short/jpet.108.143511v1?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://jpet.aspetjournals.org/cgi/content/short/jpet.108.145011v1?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://jpet.aspetjournals.org/cgi/content/short/313/2/909?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://jpet.aspetjournals.org/cgi/content/short/304/3/1280?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://jpet.aspetjournals.org/cgi/content/short/321/1/1?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://jpet.aspetjournals.org/cgi/content/short/317/3/1114?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://jpet.aspetjournals.org/cgi/content/short/307/3/1179?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://jpet.aspetjournals.org/cgi/content/short/322/2/709?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://jpet.aspetjournals.org/cgi/content/short/327/1/268?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://jpet.aspetjournals.org/cgi/content/short/jpet.108.143271v1?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://jpet.aspetjournals.org/cgi/content/short/321/3/892?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://jpet.aspetjournals.org/cgi/content/short/320/2/535?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://jpet.aspetjournals.org/cgi/content/short/jpet.108.143719v1?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://jpet.aspetjournals.org/cgi/content/short/299/2/775?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://jpet.aspetjournals.org/cgi/content/short/322/3/1013?rss=1&amp;ssource=mfc" />
 </rdf:Seq>
</items>
</channel>

<item rdf:about="http://jpet.aspetjournals.org/cgi/content/short/286/3/1404?rss=1&amp;ssource=mfc">
<title><![CDATA[Purification of Two Rat Hepatic Proteins with A-Esterase Activity Toward Chlorpyrifos-Oxon and Paraoxon]]></title>
<link>http://jpet.aspetjournals.org/cgi/content/short/286/3/1404?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Amber L. Pond, Howard W. Chambers, Cody P. Coyne, Janice E. Chambers<br />Sep  1, 1998; 286:1404-1411<br />ARTICLES]]></description>
<dc:creator>Amber L. Pond, Howard W. Chambers, Cody P. Coyne, Janice E. Chambers</dc:creator>
<dc:date>1998-09-01</dc:date>
<dc:title><![CDATA[Purification of Two Rat Hepatic Proteins with A-Esterase Activity Toward Chlorpyrifos-Oxon and Paraoxon]]></dc:title>
<dc:publisher>American Society for Pharmacology and Experimental Therapeutics</dc:publisher>
</item>

<item rdf:about="http://jpet.aspetjournals.org/cgi/content/short/309/2/484?rss=1&amp;ssource=mfc">
<title><![CDATA[Evidence for Multiple P2Y Receptors in Trabecular Meshwork Cells]]></title>
<link>http://jpet.aspetjournals.org/cgi/content/short/309/2/484?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Craig E. Crosson, Phillip W. Yates, Aruna N. Bhat, Yurii V. Mukhin, Shahid Husain<br />May  1, 2004; 309:484-489<br />]]></description>
<dc:creator>Craig E. Crosson, Phillip W. Yates, Aruna N. Bhat, Yurii V. Mukhin, Shahid Husain</dc:creator>
<dc:date>2004-05-01</dc:date>
<dc:title><![CDATA[Evidence for Multiple P2Y Receptors in Trabecular Meshwork Cells]]></dc:title>
<dc:publisher>American Society for Pharmacology and Experimental Therapeutics</dc:publisher>
</item>

<item rdf:about="http://jpet.aspetjournals.org/cgi/content/short/288/2/714?rss=1&amp;ssource=mfc">
<title><![CDATA[Lead Stimulates Lymphocyte Proliferation Through Enhanced T Cell-B Cell Interaction]]></title>
<link>http://jpet.aspetjournals.org/cgi/content/short/288/2/714?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Seddigheh Razani-Boroujerdi, Bruce Edwards, Mohan L. Sopori<br />Feb  1, 1999; 288:714-719<br />ARTICLES]]></description>
<dc:creator>Seddigheh Razani-Boroujerdi, Bruce Edwards, Mohan L. Sopori</dc:creator>
<dc:date>1999-02-01</dc:date>
<dc:title><![CDATA[Lead Stimulates Lymphocyte Proliferation Through Enhanced T Cell-B Cell Interaction]]></dc:title>
<dc:publisher>American Society for Pharmacology and Experimental Therapeutics</dc:publisher>
</item>

<item rdf:about="http://jpet.aspetjournals.org/cgi/content/short/jpet.107.132225v1?rss=1&amp;ssource=mfc">
<title><![CDATA[The role of ABC transporters in tissue defense and organ regeneration]]></title>
<link>http://jpet.aspetjournals.org/cgi/content/short/jpet.107.132225v1?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Miriam Huls, Frans G.M. Russel, Rosalinde Masereeuw<br />Sep 12, 2008; 0:107132225<br />]]></description>
<dc:creator>Miriam Huls, Frans G.M. Russel, Rosalinde Masereeuw</dc:creator>
<dc:date>2008-09-12</dc:date>
<dc:title><![CDATA[The role of ABC transporters in tissue defense and organ regeneration]]></dc:title>
<dc:publisher>American Society for Pharmacology and Experimental Therapeutics</dc:publisher>
</item>

<item rdf:about="http://jpet.aspetjournals.org/cgi/content/short/298/3/865?rss=1&amp;ssource=mfc">
<title><![CDATA[Drug Synergism: Its Detection and Applications]]></title>
<link>http://jpet.aspetjournals.org/cgi/content/short/298/3/865?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Ronald J. Tallarida<br />Sep  1, 2001; 298:865-872<br />PERSPECTIVES IN PHARMACOLOGY]]></description>
<dc:creator>Ronald J. Tallarida</dc:creator>
<dc:date>2001-09-01</dc:date>
<dc:title><![CDATA[Drug Synergism: Its Detection and Applications]]></dc:title>
<dc:publisher>American Society for Pharmacology and Experimental Therapeutics</dc:publisher>
</item>

<item rdf:about="http://jpet.aspetjournals.org/cgi/content/short/294/2/735?rss=1&amp;ssource=mfc">
<title><![CDATA[Disposition of Glutathione Conjugates in Rats by a Novel Glutamic Acid Pathway: Characterization of Unique Peptide Conjugates by Liquid Chromatography/Mass Spectrometry and Liquid Chromatography/NMR]]></title>
<link>http://jpet.aspetjournals.org/cgi/content/short/294/2/735?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Abdul E. Mutlib, John Shockcor, Robert Espina, Nilsa Graciani, Alicia Du, Liang-Shang Gan<br />Aug  1, 2000; 294:735-745<br />ABSORPTION, DISTRIBUTION, METABOLISM, AND EXCRETION]]></description>
<dc:creator>Abdul E. Mutlib, John Shockcor, Robert Espina, Nilsa Graciani, Alicia Du, Liang-Shang Gan</dc:creator>
<dc:date>2000-08-01</dc:date>
<dc:title><![CDATA[Disposition of Glutathione Conjugates in Rats by a Novel Glutamic Acid Pathway: Characterization of Unique Peptide Conjugates by Liquid Chromatography/Mass Spectrometry and Liquid Chromatography/NMR]]></dc:title>
<dc:publisher>American Society for Pharmacology and Experimental Therapeutics</dc:publisher>
</item>

<item rdf:about="http://jpet.aspetjournals.org/cgi/content/short/314/2/883?rss=1&amp;ssource=mfc">
<title><![CDATA[Amino Acid Ester Prodrugs of 2-Bromo-5,6-dichloro-1-({beta}-D-ribofuranosyl)benzimidazole Enhance Metabolic Stability in Vitro and in Vivo]]></title>
<link>http://jpet.aspetjournals.org/cgi/content/short/314/2/883?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Philip L. Lorenzi, Christopher P. Landowski, Xueqin Song, Katherine Z. Borysko, Julie M. Breitenbach, Jae Seung Kim, John M. Hilfinger, Leroy B. Townsend, John C. Drach, Gordon L. Amidon<br />Aug  1, 2005; 314:883-890<br />ABSORPTION, DISTRIBUTION, METABOLISM, AND EXCRETION]]></description>
<dc:creator>Philip L. Lorenzi, Christopher P. Landowski, Xueqin Song, Katherine Z. Borysko, Julie M. Breitenbach, Jae Seung Kim, John M. Hilfinger, Leroy B. Townsend, John C. Drach, Gordon L. Amidon</dc:creator>
<dc:date>2005-08-01</dc:date>
<dc:title><![CDATA[Amino Acid Ester Prodrugs of 2-Bromo-5,6-dichloro-1-({beta}-D-ribofuranosyl)benzimidazole Enhance Metabolic Stability in Vitro and in Vivo]]></dc:title>
<dc:publisher>American Society for Pharmacology and Experimental Therapeutics</dc:publisher>
</item>

<item rdf:about="http://jpet.aspetjournals.org/cgi/content/short/318/2/657?rss=1&amp;ssource=mfc">
<title><![CDATA[Desvenlafaxine Succinate: A New Serotonin and Norepinephrine Reuptake Inhibitor]]></title>
<link>http://jpet.aspetjournals.org/cgi/content/short/318/2/657?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Darlene C. Deecher, Chad E. Beyer, Grace Johnston, Jenifer Bray, S. Shah, M. Abou-Gharbia, Terrance H. Andree<br />Aug  1, 2006; 318:657-665<br />NEUROPHARMACOLOGY]]></description>
<dc:creator>Darlene C. Deecher, Chad E. Beyer, Grace Johnston, Jenifer Bray, S. Shah, M. Abou-Gharbia, Terrance H. Andree</dc:creator>
<dc:date>2006-08-01</dc:date>
<dc:title><![CDATA[Desvenlafaxine Succinate: A New Serotonin and Norepinephrine Reuptake Inhibitor]]></dc:title>
<dc:publisher>American Society for Pharmacology and Experimental Therapeutics</dc:publisher>
</item>

<item rdf:about="http://jpet.aspetjournals.org/cgi/content/short/320/1/323?rss=1&amp;ssource=mfc">
<title><![CDATA[Sergliflozin, a Novel Selective Inhibitor of Low-Affinity Sodium Glucose Cotransporter (SGLT2), Validates the Critical Role of SGLT2 in Renal Glucose Reabsorption and Modulates Plasma Glucose Level]]></title>
<link>http://jpet.aspetjournals.org/cgi/content/short/320/1/323?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Kenji Katsuno, Yoshikazu Fujimori, Yukiko Takemura, Masahiro Hiratochi, Fumiaki Itoh, Yoshimitsu Komatsu, Hideki Fujikura, Masayuki Isaji<br />Jan  1, 2007; 320:323-330<br />]]></description>
<dc:creator>Kenji Katsuno, Yoshikazu Fujimori, Yukiko Takemura, Masahiro Hiratochi, Fumiaki Itoh, Yoshimitsu Komatsu, Hideki Fujikura, Masayuki Isaji</dc:creator>
<dc:date>2007-01-01</dc:date>
<dc:title><![CDATA[Sergliflozin, a Novel Selective Inhibitor of Low-Affinity Sodium Glucose Cotransporter (SGLT2), Validates the Critical Role of SGLT2 in Renal Glucose Reabsorption and Modulates Plasma Glucose Level]]></dc:title>
<dc:publisher>American Society for Pharmacology and Experimental Therapeutics</dc:publisher>
</item>

<item rdf:about="http://jpet.aspetjournals.org/cgi/content/short/300/1/118?rss=1&amp;ssource=mfc">
<title><![CDATA[Effects of Subcutaneous Methylnaltrexone on Morphine-Induced Peripherally Mediated Side Effects: A Double-Blind Randomized Placebo-Controlled Trial]]></title>
<link>http://jpet.aspetjournals.org/cgi/content/short/300/1/118?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Chun-Su Yuan, Gang Wei, Joseph F. Foss, Michael O''Connor, Theodore Karrison, Joachim Osinski<br />Jan  1, 2002; 300:118-123<br />NEUROPHARMACOLOGY]]></description>
<dc:creator>Chun-Su Yuan, Gang Wei, Joseph F. Foss, Michael O''Connor, Theodore Karrison, Joachim Osinski</dc:creator>
<dc:date>2002-01-01</dc:date>
<dc:identifier>10.1124/jpet.300.1.118</dc:identifier>
<dc:title><![CDATA[Effects of Subcutaneous Methylnaltrexone on Morphine-Induced Peripherally Mediated Side Effects: A Double-Blind Randomized Placebo-Controlled Trial]]></dc:title>
<dc:publisher>American Society for Pharmacology and Experimental Therapeutics</dc:publisher>
</item>

<item rdf:about="http://jpet.aspetjournals.org/cgi/content/short/315/3/971?rss=1&amp;ssource=mfc">
<title><![CDATA[Role of Tyrosine Kinase Inhibitors in Cancer Therapy]]></title>
<link>http://jpet.aspetjournals.org/cgi/content/short/315/3/971?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Amit Arora, Eric M. Scholar<br />Dec  1, 2005; 315:971-979<br />PERSPECTIVES IN PHARMACOLOGY]]></description>
<dc:creator>Amit Arora, Eric M. Scholar</dc:creator>
<dc:date>2005-12-01</dc:date>
<dc:title><![CDATA[Role of Tyrosine Kinase Inhibitors in Cancer Therapy]]></dc:title>
<dc:publisher>American Society for Pharmacology and Experimental Therapeutics</dc:publisher>
</item>

<item rdf:about="http://jpet.aspetjournals.org/cgi/content/short/285/3/931?rss=1&amp;ssource=mfc">
<title><![CDATA[Fetal Nicotine or Cocaine Exposure: Which One is Worse?]]></title>
<link>http://jpet.aspetjournals.org/cgi/content/short/285/3/931?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Theodore A. Slotkin<br />Jun  1, 1998; 285:931-945<br />THE 1998 ASPET OTTO KRAYER AWARD LECTURE]]></description>
<dc:creator>Theodore A. Slotkin</dc:creator>
<dc:date>1998-06-01</dc:date>
<dc:title><![CDATA[Fetal Nicotine or Cocaine Exposure: Which One is Worse?]]></dc:title>
<dc:publisher>American Society for Pharmacology and Experimental Therapeutics</dc:publisher>
</item>

<item rdf:about="http://jpet.aspetjournals.org/cgi/content/short/jpet.108.144154v1?rss=1&amp;ssource=mfc">
<title><![CDATA[CNTO736, a Novel GLP-1 Receptor Agonist, Ameliorates Insulin Resistance and Inhibits Very Low Density Lipoprotein Production in High-Fat-Fed Mice]]></title>
<link>http://jpet.aspetjournals.org/cgi/content/short/jpet.108.144154v1?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Edwin T. Parlevliet, Janny P. Schroder-van der Elst, Eleonora P.M. Corssmit, Kristen Picha, Karyn O''Neil, Vedrana Stojanovic-Susulic, Tatiana Ort, Louis M. Havekes, Johannes A. Romijn, Hanno Pijl<br />Oct 10, 2008; 0:108144154<br />Metabolism, Transport, and Pharmacogenomics]]></description>
<dc:creator>Edwin T. Parlevliet, Janny P. Schroder-van der Elst, Eleonora P.M. Corssmit, Kristen Picha, Karyn O''Neil, Vedrana Stojanovic-Susulic, Tatiana Ort, Louis M. Havekes, Johannes A. Romijn, Hanno Pijl</dc:creator>
<dc:date>2008-10-10</dc:date>
<dc:title><![CDATA[CNTO736, a Novel GLP-1 Receptor Agonist, Ameliorates Insulin Resistance and Inhibits Very Low Density Lipoprotein Production in High-Fat-Fed Mice]]></dc:title>
<dc:publisher>American Society for Pharmacology and Experimental Therapeutics</dc:publisher>
</item>

<item rdf:about="http://jpet.aspetjournals.org/cgi/content/short/320/1/1?rss=1&amp;ssource=mfc">
<title><![CDATA[Functional Selectivity and Classical Concepts of Quantitative Pharmacology]]></title>
<link>http://jpet.aspetjournals.org/cgi/content/short/320/1/1?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Jonathan D. Urban, William P. Clarke, Mark von Zastrow, David E. Nichols, Brian Kobilka, Harel Weinstein, Jonathan A. Javitch, Bryan L. Roth, Arthur Christopoulos, Patrick M. Sexton, Keith J. Miller, Michael Spedding, Richard B. Mailman<br />Jan  1, 2007; 320:1-13<br />PERSPECTIVES IN PHARMACOLOGY]]></description>
<dc:creator>Jonathan D. Urban, William P. Clarke, Mark von Zastrow, David E. Nichols, Brian Kobilka, Harel Weinstein, Jonathan A. Javitch, Bryan L. Roth, Arthur Christopoulos, Patrick M. Sexton, Keith J. Miller, Michael Spedding, Richard B. Mailman</dc:creator>
<dc:date>2007-01-01</dc:date>
<dc:title><![CDATA[Functional Selectivity and Classical Concepts of Quantitative Pharmacology]]></dc:title>
<dc:publisher>American Society for Pharmacology and Experimental Therapeutics</dc:publisher>
</item>

<item rdf:about="http://jpet.aspetjournals.org/cgi/content/short/jpet.108.143628v1?rss=1&amp;ssource=mfc">
<title><![CDATA[First demonstration of CSF and plasma A{beta} lowering with oral administration of a BACE1 inhibitor in nonhuman primates]]></title>
<link>http://jpet.aspetjournals.org/cgi/content/short/jpet.108.143628v1?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Sethu Sankaranarayanan, Marie A. Holahan, Dennis Colussi, Ming-Chih Crouthamel, Viswanath Devanarayan, Joan Ellis, Amy Espeseth, Adam T. Gates, Samuel L. Graham, Allison R. Gregro, Daria Hazuda, Jerome H. Hochman, Katharine Holloway, Lixia Jin, Jason Kahana, Ming-tain Lai, Janet Lineberger, Georgia McGaughey, Keith P. Moore, Philippe Nantermet, Beth Pietrak, Eric A. Price, Hemaka Rajapakse, Shaun Stauffer, Melissa A. Steinbeiser, Guy Seabrook, Harold G. Selnick, Xiao-Ping Shi, Matthew G. Stanton, John Swestock, Katherine Tugusheva, Keala X. Tyler, Joseph P. Vacca, Jacky Wong, Guoxin Wu, Min Xu, Jacquelynn J. Cook, Adam J. Simon<br />Oct 14, 2008; 0:108143628<br />]]></description>
<dc:creator>Sethu Sankaranarayanan, Marie A. Holahan, Dennis Colussi, Ming-Chih Crouthamel, Viswanath Devanarayan, Joan Ellis, Amy Espeseth, Adam T. Gates, Samuel L. Graham, Allison R. Gregro, Daria Hazuda, Jerome H. Hochman, Katharine Holloway, Lixia Jin, Jason Kahana, Ming-tain Lai, Janet Lineberger, Georgia McGaughey, Keith P. Moore, Philippe Nantermet, Beth Pietrak, Eric A. Price, Hemaka Rajapakse, Shaun Stauffer, Melissa A. Steinbeiser, Guy Seabrook, Harold G. Selnick, Xiao-Ping Shi, Matthew G. Stanton, John Swestock, Katherine Tugusheva, Keala X. Tyler, Joseph P. Vacca, Jacky Wong, Guoxin Wu, Min Xu, Jacquelynn J. Cook, Adam J. Simon</dc:creator>
<dc:date>2008-10-14</dc:date>
<dc:title><![CDATA[First demonstration of CSF and plasma A{beta} lowering with oral administration of a BACE1 inhibitor in nonhuman primates]]></dc:title>
<dc:publisher>American Society for Pharmacology and Experimental Therapeutics</dc:publisher>
</item>

<item rdf:about="http://jpet.aspetjournals.org/cgi/content/short/327/2/287-a?rss=1&amp;ssource=mfc">
<title><![CDATA[An Unexpected Role for Peripheral Serotonin 5-HT2A Receptors]]></title>
<link>http://jpet.aspetjournals.org/cgi/content/short/327/2/287-a?rss=1&amp;ssource=mfc</link>
<description><![CDATA[<br />Nov  1, 2008; 327:287-287<br />HIGHLIGHTED PAPERS]]></description>
<dc:date>2008-11-01</dc:date>
<dc:title><![CDATA[An Unexpected Role for Peripheral Serotonin 5-HT2A Receptors]]></dc:title>
<dc:publisher>American Society for Pharmacology and Experimental Therapeutics</dc:publisher>
</item>

<item rdf:about="http://jpet.aspetjournals.org/cgi/content/short/jpet.108.140798v1?rss=1&amp;ssource=mfc">
<title><![CDATA[A Cross-Link between Protein Kinase A and Rho-Family GTPases Signaling Mediates Cell-Cell Adhesion and Actin Cytoskeleton Organization in Epithelial Cancer Cells]]></title>
<link>http://jpet.aspetjournals.org/cgi/content/short/jpet.108.140798v1?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Fernanda Leve, Wanderley de Souza, Jose Andres Morgado-Diaz<br />Dec  1, 2008; 327:777-788<br />GASTROINTESTINAL, HEPATIC, PULMONARY, AND RENAL]]></description>
<dc:creator>Fernanda Leve, Wanderley de Souza, Jose Andres Morgado-Diaz</dc:creator>
<dc:date>2008-12-01</dc:date>
<dc:title><![CDATA[A Cross-Link between Protein Kinase A and Rho-Family GTPases Signaling Mediates Cell-Cell Adhesion and Actin Cytoskeleton Organization in Epithelial Cancer Cells]]></dc:title>
<dc:publisher>American Society for Pharmacology and Experimental Therapeutics</dc:publisher>
</item>

<item rdf:about="http://jpet.aspetjournals.org/cgi/content/short/jpet.108.142315v1?rss=1&amp;ssource=mfc">
<title><![CDATA[Antidepressants Targeting the Serotonin Reuptake Transporter Act via a Competitive Mechanism]]></title>
<link>http://jpet.aspetjournals.org/cgi/content/short/jpet.108.142315v1?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Subbu Apparsundaram, Daniel J. Stockdale, Robert A. Henningsen, Marcos E. Milla, Renee S. Martin<br />Dec  1, 2008; 327:982-990<br />NEUROPHARMACOLOGY]]></description>
<dc:creator>Subbu Apparsundaram, Daniel J. Stockdale, Robert A. Henningsen, Marcos E. Milla, Renee S. Martin</dc:creator>
<dc:date>2008-12-01</dc:date>
<dc:title><![CDATA[Antidepressants Targeting the Serotonin Reuptake Transporter Act via a Competitive Mechanism]]></dc:title>
<dc:publisher>American Society for Pharmacology and Experimental Therapeutics</dc:publisher>
</item>

<item rdf:about="http://jpet.aspetjournals.org/cgi/content/short/303/3/889?rss=1&amp;ssource=mfc">
<title><![CDATA[Predicting Drug Absorption: How Nature Made It a Difficult Problem]]></title>
<link>http://jpet.aspetjournals.org/cgi/content/short/303/3/889?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Philip S. Burton, Jay T. Goodwin, Thomas J. Vidmar, Benny M. Amore<br />Dec  1, 2002; 303:889-895<br />PERSPECTIVES IN PHARMACOLOGY]]></description>
<dc:creator>Philip S. Burton, Jay T. Goodwin, Thomas J. Vidmar, Benny M. Amore</dc:creator>
<dc:date>2002-12-01</dc:date>
<dc:identifier>10.1124/jpet.102.035006</dc:identifier>
<dc:title><![CDATA[Predicting Drug Absorption: How Nature Made It a Difficult Problem]]></dc:title>
<dc:publisher>American Society for Pharmacology and Experimental Therapeutics</dc:publisher>
</item>

<item rdf:about="http://jpet.aspetjournals.org/cgi/content/short/jpet.108.136580v1?rss=1&amp;ssource=mfc">
<title><![CDATA[ADX47273 [S-(4-Fluoro-phenyl)-{3-[3-(4-fluoro-phenyl)-[1,2,4]-oxadiazol-5-yl]-piperidin-1-yl}-methanone]: A Novel Metabotropic Glutamate Receptor 5-Selective Positive Allosteric Modulator with Preclinical Antipsychotic-Like and Procognitive Activities]]></title>
<link>http://jpet.aspetjournals.org/cgi/content/short/jpet.108.136580v1?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Feng Liu, Steve Grauer, Cody Kelley, Rachel Navarra, Radka Graf, Guoming Zhang, Peter J. Atkinson, Michael Popiolek, Caitlin Wantuch, Xavier Khawaja, Deborah Smith, Michael Olsen, Evguenia Kouranova, Margaret Lai, Farhana Pruthi, Claudine Pulicicchio, Mark Day, Adam Gilbert, Mark H. Pausch, Nicholas J. Brandon, Chad E. Beyer, Tom A. Comery, Sheree Logue, Sharon Rosenzweig-Lipson, Karen L. Marquis<br />Dec  1, 2008; 327:827-839<br />NEUROPHARMACOLOGY]]></description>
<dc:creator>Feng Liu, Steve Grauer, Cody Kelley, Rachel Navarra, Radka Graf, Guoming Zhang, Peter J. Atkinson, Michael Popiolek, Caitlin Wantuch, Xavier Khawaja, Deborah Smith, Michael Olsen, Evguenia Kouranova, Margaret Lai, Farhana Pruthi, Claudine Pulicicchio, Mark Day, Adam Gilbert, Mark H. Pausch, Nicholas J. Brandon, Chad E. Beyer, Tom A. Comery, Sheree Logue, Sharon Rosenzweig-Lipson, Karen L. Marquis</dc:creator>
<dc:date>2008-12-01</dc:date>
<dc:title><![CDATA[ADX47273 [S-(4-Fluoro-phenyl)-{3-[3-(4-fluoro-phenyl)-[1,2,4]-oxadiazol-5-yl]-piperidin-1-yl}-methanone]: A Novel Metabotropic Glutamate Receptor 5-Selective Positive Allosteric Modulator with Preclinical Antipsychotic-Like and Procognitive Activities]]></dc:title>
<dc:publisher>American Society for Pharmacology and Experimental Therapeutics</dc:publisher>
</item>

<item rdf:about="http://jpet.aspetjournals.org/cgi/content/short/301/3/820?rss=1&amp;ssource=mfc">
<title><![CDATA[Role of PEPT2 in Peptide/Mimetic Trafficking at the Blood-Cerebrospinal Fluid Barrier: Studies in Rat Choroid Plexus Epithelial Cells in Primary Culture]]></title>
<link>http://jpet.aspetjournals.org/cgi/content/short/301/3/820?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Cathaleen Shu, Hong Shen, Nathan S. Teuscher, Philip J. Lorenzi, Richard F. Keep, David E. Smith<br />Jun  1, 2002; 301:820-829<br />ABSORPTION, DISTRIBUTION, METABOLISM, AND EXCRETION]]></description>
<dc:creator>Cathaleen Shu, Hong Shen, Nathan S. Teuscher, Philip J. Lorenzi, Richard F. Keep, David E. Smith</dc:creator>
<dc:date>2002-06-01</dc:date>
<dc:identifier>10.1124/jpet.301.3.820</dc:identifier>
<dc:title><![CDATA[Role of PEPT2 in Peptide/Mimetic Trafficking at the Blood-Cerebrospinal Fluid Barrier: Studies in Rat Choroid Plexus Epithelial Cells in Primary Culture]]></dc:title>
<dc:publisher>American Society for Pharmacology and Experimental Therapeutics</dc:publisher>
</item>

<item rdf:about="http://jpet.aspetjournals.org/cgi/content/short/323/1/265?rss=1&amp;ssource=mfc">
<title><![CDATA[( )-(1R,2R)-3-(3-Dimethylamino-1-ethyl-2-methyl-propyl)-phenol Hydrochloride (Tapentadol HCl): a Novel {micro}-Opioid Receptor Agonist/Norepinephrine Reuptake Inhibitor with Broad-Spectrum Analgesic Properties]]></title>
<link>http://jpet.aspetjournals.org/cgi/content/short/323/1/265?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Thomas M. Tzschentke, Thomas Christoph, Babette Kogel, Klaus Schiene, Hagen-Heinrich Hennies, Werner Englberger, Michael Haurand, Ulrich Jahnel, Thomas I. F. H. Cremers, Elmar Friderichs, Jean De Vry<br />Oct  1, 2007; 323:265-276<br />NEUROPHARMACOLOGY]]></description>
<dc:creator>Thomas M. Tzschentke, Thomas Christoph, Babette Kogel, Klaus Schiene, Hagen-Heinrich Hennies, Werner Englberger, Michael Haurand, Ulrich Jahnel, Thomas I. F. H. Cremers, Elmar Friderichs, Jean De Vry</dc:creator>
<dc:date>2007-10-01</dc:date>
<dc:title><![CDATA[( )-(1R,2R)-3-(3-Dimethylamino-1-ethyl-2-methyl-propyl)-phenol Hydrochloride (Tapentadol HCl): a Novel {micro}-Opioid Receptor Agonist/Norepinephrine Reuptake Inhibitor with Broad-Spectrum Analgesic Properties]]></dc:title>
<dc:publisher>American Society for Pharmacology and Experimental Therapeutics</dc:publisher>
</item>

<item rdf:about="http://jpet.aspetjournals.org/cgi/content/short/jpet.108.142703v1?rss=1&amp;ssource=mfc">
<title><![CDATA[Combination of the Dipeptidyl Peptidase IV Inhibitor LAF237 [(S)-1-[(3-Hydroxy-1-adamantyl)ammo]acetyl-2-cyanopyrrolidine] with the Angiotensin II Type 1 Receptor Antagonist Valsartan [N-(1-Oxopentyl)-N-[[2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]methyl]-L-valine] Enhances Pancreatic Islet Morphology and Function in a Mouse Model of Type 2 Diabetes]]></title>
<link>http://jpet.aspetjournals.org/cgi/content/short/jpet.108.142703v1?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Qianni Cheng, Pui Ki Law, Marc de Gasparo, Po Sing Leung<br />Dec  1, 2008; 327:683-691<br />]]></description>
<dc:creator>Qianni Cheng, Pui Ki Law, Marc de Gasparo, Po Sing Leung</dc:creator>
<dc:date>2008-12-01</dc:date>
<dc:title><![CDATA[Combination of the Dipeptidyl Peptidase IV Inhibitor LAF237 [(S)-1-[(3-Hydroxy-1-adamantyl)ammo]acetyl-2-cyanopyrrolidine] with the Angiotensin II Type 1 Receptor Antagonist Valsartan [N-(1-Oxopentyl)-N-[[2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]methyl]-L-valine] Enhances Pancreatic Islet Morphology and Function in a Mouse Model of Type 2 Diabetes]]></dc:title>
<dc:publisher>American Society for Pharmacology and Experimental Therapeutics</dc:publisher>
</item>

<item rdf:about="http://jpet.aspetjournals.org/cgi/content/short/jpet.108.145102v1?rss=1&amp;ssource=mfc">
<title><![CDATA[Epoxyeicosatrienoic Acids Function as Selective, Endogenous Antagonists of Native Thromboxane Receptors: Identification of a Novel Mechanism of Vasodilation]]></title>
<link>http://jpet.aspetjournals.org/cgi/content/short/jpet.108.145102v1?rss=1&amp;ssource=mfc</link>
<description><![CDATA[David J Behm, Andrea Ogbonna, Charlene Wu, Cynthia L Burns-Kurtis, Stephen A Douglas<br />Oct  3, 2008; 0:108145102<br />]]></description>
<dc:creator>David J Behm, Andrea Ogbonna, Charlene Wu, Cynthia L Burns-Kurtis, Stephen A Douglas</dc:creator>
<dc:date>2008-10-03</dc:date>
<dc:title><![CDATA[Epoxyeicosatrienoic Acids Function as Selective, Endogenous Antagonists of Native Thromboxane Receptors: Identification of a Novel Mechanism of Vasodilation]]></dc:title>
<dc:publisher>American Society for Pharmacology and Experimental Therapeutics</dc:publisher>
</item>

<item rdf:about="http://jpet.aspetjournals.org/cgi/content/short/jpet.108.141853v1?rss=1&amp;ssource=mfc">
<title><![CDATA[Characterization of N-(Adamantan-1-ylmethyl)-5-[(3R-aminopyrrolidin-1-yl)methyl]-2-chloro-benzamide, a P2X7 Antagonist in Animal Models of Pain and Inflammation]]></title>
<link>http://jpet.aspetjournals.org/cgi/content/short/jpet.108.141853v1?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Daniel C. Broom, David J. Matson, Elizabeth Bradshaw, Marianne E. Buck, Robin Meade, Susan Coombs, Michele Matchett, Kristen K. Ford, Weifeng Yu, Jun Yuan, Synthia H. Sun, Ricardo Ochoa, James E. Krause, David J. Wustrow, Daniel N. Cortright<br />Dec  1, 2008; 327:620-633<br />]]></description>
<dc:creator>Daniel C. Broom, David J. Matson, Elizabeth Bradshaw, Marianne E. Buck, Robin Meade, Susan Coombs, Michele Matchett, Kristen K. Ford, Weifeng Yu, Jun Yuan, Synthia H. Sun, Ricardo Ochoa, James E. Krause, David J. Wustrow, Daniel N. Cortright</dc:creator>
<dc:date>2008-12-01</dc:date>
<dc:title><![CDATA[Characterization of N-(Adamantan-1-ylmethyl)-5-[(3R-aminopyrrolidin-1-yl)methyl]-2-chloro-benzamide, a P2X7 Antagonist in Animal Models of Pain and Inflammation]]></dc:title>
<dc:publisher>American Society for Pharmacology and Experimental Therapeutics</dc:publisher>
</item>

<item rdf:about="http://jpet.aspetjournals.org/cgi/content/short/281/1/103?rss=1&amp;ssource=mfc">
<title><![CDATA[Inhibition of Cytochrome P450 2D6 Metabolism of Hydrocodone to Hydromorphone Does Not Importantly Affect Abuse Liability]]></title>
<link>http://jpet.aspetjournals.org/cgi/content/short/281/1/103?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Howard L. Kaplan, Usoa E. Busto, Godofredo J. Baylon, Siu W. Cheung, S. Victoria Otton, Gail Somer, Edward M. Sellers<br />Apr  1, 1997; 281:103-108<br />DRUG METABOLISM AND DISPOSITION]]></description>
<dc:creator>Howard L. Kaplan, Usoa E. Busto, Godofredo J. Baylon, Siu W. Cheung, S. Victoria Otton, Gail Somer, Edward M. Sellers</dc:creator>
<dc:date>1997-04-01</dc:date>
<dc:title><![CDATA[Inhibition of Cytochrome P450 2D6 Metabolism of Hydrocodone to Hydromorphone Does Not Importantly Affect Abuse Liability]]></dc:title>
<dc:publisher>American Society for Pharmacology and Experimental Therapeutics</dc:publisher>
</item>

<item rdf:about="http://jpet.aspetjournals.org/cgi/content/short/327/2/287?rss=1&amp;ssource=mfc">
<title><![CDATA[Dissecting Oxidative Stress following Ischemic Reperfusion]]></title>
<link>http://jpet.aspetjournals.org/cgi/content/short/327/2/287?rss=1&amp;ssource=mfc</link>
<description><![CDATA[<br />Nov  1, 2008; 327:287-287<br />HIGHLIGHTED PAPERS]]></description>
<dc:date>2008-11-01</dc:date>
<dc:title><![CDATA[Dissecting Oxidative Stress following Ischemic Reperfusion]]></dc:title>
<dc:publisher>American Society for Pharmacology and Experimental Therapeutics</dc:publisher>
</item>

<item rdf:about="http://jpet.aspetjournals.org/cgi/content/short/304/1/1?rss=1&amp;ssource=mfc">
<title><![CDATA[Role of Microglia in Inflammation-Mediated Neurodegenerative Diseases: Mechanisms and Strategies for Therapeutic Intervention]]></title>
<link>http://jpet.aspetjournals.org/cgi/content/short/304/1/1?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Bin Liu, Jau-Shyong Hong<br />Jan  1, 2003; 304:1-7<br />PERSPECTIVES IN PHARMACOLOGY]]></description>
<dc:creator>Bin Liu, Jau-Shyong Hong</dc:creator>
<dc:date>2003-01-01</dc:date>
<dc:identifier>10.1124/jpet.102.035048</dc:identifier>
<dc:title><![CDATA[Role of Microglia in Inflammation-Mediated Neurodegenerative Diseases: Mechanisms and Strategies for Therapeutic Intervention]]></dc:title>
<dc:publisher>American Society for Pharmacology and Experimental Therapeutics</dc:publisher>
</item>

<item rdf:about="http://jpet.aspetjournals.org/cgi/content/short/313/3/1217?rss=1&amp;ssource=mfc">
<title><![CDATA[Relative Bioavailability of Calcium from Calcium Formate, Calcium Citrate, and Calcium Carbonate]]></title>
<link>http://jpet.aspetjournals.org/cgi/content/short/313/3/1217?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Robert P. Hanzlik, Stephen C. Fowler, Daniel H. Fisher<br />Jun  1, 2005; 313:1217-1222<br />ABSORPTION, DISTRIBUTION, METABOLISM, AND EXCRETION]]></description>
<dc:creator>Robert P. Hanzlik, Stephen C. Fowler, Daniel H. Fisher</dc:creator>
<dc:date>2005-06-01</dc:date>
<dc:title><![CDATA[Relative Bioavailability of Calcium from Calcium Formate, Calcium Citrate, and Calcium Carbonate]]></dc:title>
<dc:publisher>American Society for Pharmacology and Experimental Therapeutics</dc:publisher>
</item>

<item rdf:about="http://jpet.aspetjournals.org/cgi/content/short/jpet.108.139006v1?rss=1&amp;ssource=mfc">
<title><![CDATA[Pamapimod, a Novel p38 Mitogen-Activated Protein Kinase Inhibitor: Preclinical Analysis of Efficacy and Selectivity]]></title>
<link>http://jpet.aspetjournals.org/cgi/content/short/jpet.108.139006v1?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Ronald J. Hill, Karim Dabbagh, Deborah Phippard, Ching Li, Rebecca T. Suttmann, Mary Welch, Eva Papp, Kyung W. Song, Kung-ching Chang, David Leaffer, Yong-Nam Kim, Richard T. Roberts, Tanja S. Zabka, Dee Aud, Joseph Dal Porto, Anthony M. Manning, Stanford L. Peng, David M. Goldstein, Brian R. Wong<br />Dec  1, 2008; 327:610-619<br />]]></description>
<dc:creator>Ronald J. Hill, Karim Dabbagh, Deborah Phippard, Ching Li, Rebecca T. Suttmann, Mary Welch, Eva Papp, Kyung W. Song, Kung-ching Chang, David Leaffer, Yong-Nam Kim, Richard T. Roberts, Tanja S. Zabka, Dee Aud, Joseph Dal Porto, Anthony M. Manning, Stanford L. Peng, David M. Goldstein, Brian R. Wong</dc:creator>
<dc:date>2008-12-01</dc:date>
<dc:title><![CDATA[Pamapimod, a Novel p38 Mitogen-Activated Protein Kinase Inhibitor: Preclinical Analysis of Efficacy and Selectivity]]></dc:title>
<dc:publisher>American Society for Pharmacology and Experimental Therapeutics</dc:publisher>
</item>

<item rdf:about="http://jpet.aspetjournals.org/cgi/content/short/jpet.108.145219v1?rss=1&amp;ssource=mfc">
<title><![CDATA[Selectivity of Agonists for the Active State of M1 - M4 Muscarinic Receptor Subtypes]]></title>
<link>http://jpet.aspetjournals.org/cgi/content/short/jpet.108.145219v1?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Katherine W Figueroa, Michael T Griffin, Frederick J. Ehlert<br />Sep 29, 2008; 0:108145219<br />]]></description>
<dc:creator>Katherine W Figueroa, Michael T Griffin, Frederick J. Ehlert</dc:creator>
<dc:date>2008-09-29</dc:date>
<dc:title><![CDATA[Selectivity of Agonists for the Active State of M1 - M4 Muscarinic Receptor Subtypes]]></dc:title>
<dc:publisher>American Society for Pharmacology and Experimental Therapeutics</dc:publisher>
</item>

<item rdf:about="http://jpet.aspetjournals.org/cgi/content/short/jpet.108.143578v1?rss=1&amp;ssource=mfc">
<title><![CDATA[NIM811 (N-Methyl-4-isoleucine Cyclosporine), a Mitochondrial Permeability Transition Inhibitor, Attenuates Cholestatic Liver Injury but Not Fibrosis in Mice]]></title>
<link>http://jpet.aspetjournals.org/cgi/content/short/jpet.108.143578v1?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Hasibur Rehman, Venkat K. Ramshesh, Tom P. Theruvath, Insil Kim, Robert T. Currin, Shailendra Giri, John J. Lemasters, Zhi Zhong<br />Dec  1, 2008; 327:699-706<br />GASTROINTESTINAL, HEPATIC, PULMONARY, AND RENAL]]></description>
<dc:creator>Hasibur Rehman, Venkat K. Ramshesh, Tom P. Theruvath, Insil Kim, Robert T. Currin, Shailendra Giri, John J. Lemasters, Zhi Zhong</dc:creator>
<dc:date>2008-12-01</dc:date>
<dc:title><![CDATA[NIM811 (N-Methyl-4-isoleucine Cyclosporine), a Mitochondrial Permeability Transition Inhibitor, Attenuates Cholestatic Liver Injury but Not Fibrosis in Mice]]></dc:title>
<dc:publisher>American Society for Pharmacology and Experimental Therapeutics</dc:publisher>
</item>

<item rdf:about="http://jpet.aspetjournals.org/cgi/content/short/jpet.108.143883v1?rss=1&amp;ssource=mfc">
<title><![CDATA[Brainstem Adenosine A1 Receptor Signaling Masks Phosphorylated ERK1/2 Dependent Hypotensive Action of Clonidine in Conscious Normotensive Rats]]></title>
<link>http://jpet.aspetjournals.org/cgi/content/short/jpet.108.143883v1?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Noha N. Nassar, Abdel A. Abdel-Rahman<br />Oct 10, 2008; 0:108143883<br />]]></description>
<dc:creator>Noha N. Nassar, Abdel A. Abdel-Rahman</dc:creator>
<dc:date>2008-10-10</dc:date>
<dc:title><![CDATA[Brainstem Adenosine A1 Receptor Signaling Masks Phosphorylated ERK1/2 Dependent Hypotensive Action of Clonidine in Conscious Normotensive Rats]]></dc:title>
<dc:publisher>American Society for Pharmacology and Experimental Therapeutics</dc:publisher>
</item>

<item rdf:about="http://jpet.aspetjournals.org/cgi/content/short/319/3/998?rss=1&amp;ssource=mfc">
<title><![CDATA[R406, an Orally Available Spleen Tyrosine Kinase Inhibitor Blocks Fc Receptor Signaling and Reduces Immune Complex-Mediated Inflammation]]></title>
<link>http://jpet.aspetjournals.org/cgi/content/short/319/3/998?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Sylvia Braselmann, Vanessa Taylor, Haoran Zhao, Su Wang, Catherine Sylvain, Muhammad Baluom, Kunbin Qu, Ellen Herlaar, Angela Lau, Chi Young, Brian R. Wong, Scott Lovell, Thomas Sun, Gary Park, Ankush Argade, Stipo Jurcevic, Polly Pine, Rajinder Singh, Elliott B. Grossbard, Donald G. Payan, Esteban S. Masuda<br />Dec  1, 2006; 319:998-1008<br />]]></description>
<dc:creator>Sylvia Braselmann, Vanessa Taylor, Haoran Zhao, Su Wang, Catherine Sylvain, Muhammad Baluom, Kunbin Qu, Ellen Herlaar, Angela Lau, Chi Young, Brian R. Wong, Scott Lovell, Thomas Sun, Gary Park, Ankush Argade, Stipo Jurcevic, Polly Pine, Rajinder Singh, Elliott B. Grossbard, Donald G. Payan, Esteban S. Masuda</dc:creator>
<dc:date>2006-12-01</dc:date>
<dc:title><![CDATA[R406, an Orally Available Spleen Tyrosine Kinase Inhibitor Blocks Fc Receptor Signaling and Reduces Immune Complex-Mediated Inflammation]]></dc:title>
<dc:publisher>American Society for Pharmacology and Experimental Therapeutics</dc:publisher>
</item>

<item rdf:about="http://jpet.aspetjournals.org/cgi/content/short/jpet.108.145581v1?rss=1&amp;ssource=mfc">
<title><![CDATA[Decreased oral absorption of cyclosporine A after liver ischemia-reperfusion injury in rats: The contribution of CYP3A and P-glycoprotein to the first-pass metabolism in intestinal epithelial cells]]></title>
<link>http://jpet.aspetjournals.org/cgi/content/short/jpet.108.145581v1?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Kenji Ikemura, Kimihiko Urano, Hiroko Matsuda, Hideki Mizutani, Takuya Iwamoto, Masahiro OKUDA<br />Oct  8, 2008; 0:108145581<br />Metabolism, Transport, and Pharmacogenomics]]></description>
<dc:creator>Kenji Ikemura, Kimihiko Urano, Hiroko Matsuda, Hideki Mizutani, Takuya Iwamoto, Masahiro OKUDA</dc:creator>
<dc:date>2008-10-08</dc:date>
<dc:title><![CDATA[Decreased oral absorption of cyclosporine A after liver ischemia-reperfusion injury in rats: The contribution of CYP3A and P-glycoprotein to the first-pass metabolism in intestinal epithelial cells]]></dc:title>
<dc:publisher>American Society for Pharmacology and Experimental Therapeutics</dc:publisher>
</item>

<item rdf:about="http://jpet.aspetjournals.org/cgi/content/short/jpet.108.143511v1?rss=1&amp;ssource=mfc">
<title><![CDATA[Distinct roles of estrogen receptor-{alpha} and {beta} in the modulation of vascular inducible NO synthase in diabetes]]></title>
<link>http://jpet.aspetjournals.org/cgi/content/short/jpet.108.143511v1?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Andrea Cignarella, Chiara Bolego, Valeria Pelosi, Clara Meda, Andree Krust, Christian Pinna, Rosa Maria Gaion, Elisabetta Vegeto, Adriana Maggi<br />Oct  2, 2008; 0:108143511<br />]]></description>
<dc:creator>Andrea Cignarella, Chiara Bolego, Valeria Pelosi, Clara Meda, Andree Krust, Christian Pinna, Rosa Maria Gaion, Elisabetta Vegeto, Adriana Maggi</dc:creator>
<dc:date>2008-10-02</dc:date>
<dc:title><![CDATA[Distinct roles of estrogen receptor-{alpha} and {beta} in the modulation of vascular inducible NO synthase in diabetes]]></dc:title>
<dc:publisher>American Society for Pharmacology and Experimental Therapeutics</dc:publisher>
</item>

<item rdf:about="http://jpet.aspetjournals.org/cgi/content/short/jpet.108.145011v1?rss=1&amp;ssource=mfc">
<title><![CDATA[Characterization of a Cannabinoid CB2 Receptor Selective Agonist, A-836339, in In Vitro Pharmacological assays and In Vivo Pain Models]]></title>
<link>http://jpet.aspetjournals.org/cgi/content/short/jpet.108.145011v1?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Betty B Yao, Gin Hsieh, Anthony Daza, Yihong Fan, George Grayson, Tiffany Garrison, Odile El Kouhen, Bradley Hooker, Madhavi Pai, Erica Wensink, Anita Salyers, Prasant Chandran, Chang Zhu, Chengmin Zhong, Keith Ryther, Megan Gallagher, Chih-liang Chin, Ann Tovcimak, Vincent Hradil, Gerard Fox, Michael Dart, Prisca Honore, Michael Meyer<br />Oct 17, 2008; 0:108145011<br />]]></description>
<dc:creator>Betty B Yao, Gin Hsieh, Anthony Daza, Yihong Fan, George Grayson, Tiffany Garrison, Odile El Kouhen, Bradley Hooker, Madhavi Pai, Erica Wensink, Anita Salyers, Prasant Chandran, Chang Zhu, Chengmin Zhong, Keith Ryther, Megan Gallagher, Chih-liang Chin, Ann Tovcimak, Vincent Hradil, Gerard Fox, Michael Dart, Prisca Honore, Michael Meyer</dc:creator>
<dc:date>2008-10-17</dc:date>
<dc:title><![CDATA[Characterization of a Cannabinoid CB2 Receptor Selective Agonist, A-836339, in In Vitro Pharmacological assays and In Vivo Pain Models]]></dc:title>
<dc:publisher>American Society for Pharmacology and Experimental Therapeutics</dc:publisher>
</item>

<item rdf:about="http://jpet.aspetjournals.org/cgi/content/short/313/2/909?rss=1&amp;ssource=mfc">
<title><![CDATA[Dose-Related Distribution of Codeine, Cocaine, and Metabolites into Human Hair following Controlled Oral Codeine and Subcutaneous Cocaine Administration]]></title>
<link>http://jpet.aspetjournals.org/cgi/content/short/313/2/909?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Karl B. Scheidweiler, Edward J. Cone, Eric T. Moolchan, Marilyn A. Huestis<br />May  1, 2005; 313:909-915<br />ABSORPTION, DISTRIBUTION, METABOLISM, AND EXCRETION]]></description>
<dc:creator>Karl B. Scheidweiler, Edward J. Cone, Eric T. Moolchan, Marilyn A. Huestis</dc:creator>
<dc:date>2005-05-01</dc:date>
<dc:title><![CDATA[Dose-Related Distribution of Codeine, Cocaine, and Metabolites into Human Hair following Controlled Oral Codeine and Subcutaneous Cocaine Administration]]></dc:title>
<dc:publisher>American Society for Pharmacology and Experimental Therapeutics</dc:publisher>
</item>

<item rdf:about="http://jpet.aspetjournals.org/cgi/content/short/304/3/1280?rss=1&amp;ssource=mfc">
<title><![CDATA[A Long-Acting Suicide Gene Toxin, 6-Methylpurine, Inhibits Slow Growing Tumors after a Single Administration]]></title>
<link>http://jpet.aspetjournals.org/cgi/content/short/304/3/1280?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Vijayakrishna K. Gadi, Sherrie D. Alexander, William R. Waud, Paula W. Allan, William B. Parker, Eric J. Sorscher<br />Mar  1, 2003; 304:1280-1284<br />CHEMOTHERAPY, ANTIBIOTICS, AND GENE THERAPY]]></description>
<dc:creator>Vijayakrishna K. Gadi, Sherrie D. Alexander, William R. Waud, Paula W. Allan, William B. Parker, Eric J. Sorscher</dc:creator>
<dc:date>2003-03-01</dc:date>
<dc:title><![CDATA[A Long-Acting Suicide Gene Toxin, 6-Methylpurine, Inhibits Slow Growing Tumors after a Single Administration]]></dc:title>
<dc:publisher>American Society for Pharmacology and Experimental Therapeutics</dc:publisher>
</item>

<item rdf:about="http://jpet.aspetjournals.org/cgi/content/short/321/1/1?rss=1&amp;ssource=mfc">
<title><![CDATA[Therapeutic Potential of Phosphatidylinositol 3-Kinase Inhibitors in Inflammatory Respiratory Disease]]></title>
<link>http://jpet.aspetjournals.org/cgi/content/short/321/1/1?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Kazuhiro Ito, Gaetano Caramori, Ian M. Adcock<br />Apr  1, 2007; 321:1-8<br />PERSPECTIVES IN PHARMACOLOGY]]></description>
<dc:creator>Kazuhiro Ito, Gaetano Caramori, Ian M. Adcock</dc:creator>
<dc:date>2007-04-01</dc:date>
<dc:title><![CDATA[Therapeutic Potential of Phosphatidylinositol 3-Kinase Inhibitors in Inflammatory Respiratory Disease]]></dc:title>
<dc:publisher>American Society for Pharmacology and Experimental Therapeutics</dc:publisher>
</item>

<item rdf:about="http://jpet.aspetjournals.org/cgi/content/short/317/3/1114?rss=1&amp;ssource=mfc">
<title><![CDATA[A New Strategy of High-Speed Screening and Quantitative Structure-Activity Relationship Analysis to Evaluate Human ATP-Binding Cassette Transporter ABCG2-Drug Interactions]]></title>
<link>http://jpet.aspetjournals.org/cgi/content/short/317/3/1114?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Hikaru Saito, Hiroyuki Hirano, Hiroshi Nakagawa, Takeaki Fukami, Keisuke Oosumi, Kaori Murakami, Hiroko Kimura, Takayuki Kouchi, Mami Konomi, Eriko Tao, Noboru Tsujikawa, Shigeki Tarui, Makoto Nagakura, Masako Osumi, Toshihisa Ishikawa<br />Jun  1, 2006; 317:1114-1124<br />]]></description>
<dc:creator>Hikaru Saito, Hiroyuki Hirano, Hiroshi Nakagawa, Takeaki Fukami, Keisuke Oosumi, Kaori Murakami, Hiroko Kimura, Takayuki Kouchi, Mami Konomi, Eriko Tao, Noboru Tsujikawa, Shigeki Tarui, Makoto Nagakura, Masako Osumi, Toshihisa Ishikawa</dc:creator>
<dc:date>2006-06-01</dc:date>
<dc:title><![CDATA[A New Strategy of High-Speed Screening and Quantitative Structure-Activity Relationship Analysis to Evaluate Human ATP-Binding Cassette Transporter ABCG2-Drug Interactions]]></dc:title>
<dc:publisher>American Society for Pharmacology and Experimental Therapeutics</dc:publisher>
</item>

<item rdf:about="http://jpet.aspetjournals.org/cgi/content/short/307/3/1179?rss=1&amp;ssource=mfc">
<title><![CDATA[Pharmacokinetics and Pharmacodynamics of Methylecgonidine, a Crack Cocaine Pyrolyzate]]></title>
<link>http://jpet.aspetjournals.org/cgi/content/short/307/3/1179?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Karl B. Scheidweiler, Mark A. Plessinger, Jalil Shojaie, Ronald W. Wood, Tai C. Kwong<br />Dec  1, 2003; 307:1179-1187<br />TOXICOLOGY]]></description>
<dc:creator>Karl B. Scheidweiler, Mark A. Plessinger, Jalil Shojaie, Ronald W. Wood, Tai C. Kwong</dc:creator>
<dc:date>2003-12-01</dc:date>
<dc:title><![CDATA[Pharmacokinetics and Pharmacodynamics of Methylecgonidine, a Crack Cocaine Pyrolyzate]]></dc:title>
<dc:publisher>American Society for Pharmacology and Experimental Therapeutics</dc:publisher>
</item>

<item rdf:about="http://jpet.aspetjournals.org/cgi/content/short/322/2/709?rss=1&amp;ssource=mfc">
<title><![CDATA[Identification and Characterization of Cholest-4-en-3-one, Oxime (TRO19622), a Novel Drug Candidate for Amyotrophic Lateral Sclerosis]]></title>
<link>http://jpet.aspetjournals.org/cgi/content/short/322/2/709?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Thierry Bordet, Bruno Buisson, Magali Michaud, Cyrille Drouot, Pascale Galea, Pierre Delaage, Natalia P. Akentieva, Alex S. Evers, Douglas F. Covey, Mariano A. Ostuni, Jean-Jacques Lacapere, Charbel Massaad, Michael Schumacher, Esther-Marie Steidl, Delphine Maux, Michel Delaage, Christopher E. Henderson, Rebecca M. Pruss<br />Aug  1, 2007; 322:709-720<br />NEUROPHARMACOLOGY]]></description>
<dc:creator>Thierry Bordet, Bruno Buisson, Magali Michaud, Cyrille Drouot, Pascale Galea, Pierre Delaage, Natalia P. Akentieva, Alex S. Evers, Douglas F. Covey, Mariano A. Ostuni, Jean-Jacques Lacapere, Charbel Massaad, Michael Schumacher, Esther-Marie Steidl, Delphine Maux, Michel Delaage, Christopher E. Henderson, Rebecca M. Pruss</dc:creator>
<dc:date>2007-08-01</dc:date>
<dc:title><![CDATA[Identification and Characterization of Cholest-4-en-3-one, Oxime (TRO19622), a Novel Drug Candidate for Amyotrophic Lateral Sclerosis]]></dc:title>
<dc:publisher>American Society for Pharmacology and Experimental Therapeutics</dc:publisher>
</item>

<item rdf:about="http://jpet.aspetjournals.org/cgi/content/short/327/1/268?rss=1&amp;ssource=mfc">
<title><![CDATA[Remogliflozin Etabonate, in a Novel Category of Selective Low-Affinity Sodium Glucose Cotransporter (SGLT2) Inhibitors, Exhibits Antidiabetic Efficacy in Rodent Models]]></title>
<link>http://jpet.aspetjournals.org/cgi/content/short/327/1/268?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Yoshikazu Fujimori, Kenji Katsuno, Ikumi Nakashima, Yukiko Ishikawa-Takemura, Hideki Fujikura, Masayuki Isaji<br />Oct  1, 2008; 327:268-276<br />]]></description>
<dc:creator>Yoshikazu Fujimori, Kenji Katsuno, Ikumi Nakashima, Yukiko Ishikawa-Takemura, Hideki Fujikura, Masayuki Isaji</dc:creator>
<dc:date>2008-10-01</dc:date>
<dc:title><![CDATA[Remogliflozin Etabonate, in a Novel Category of Selective Low-Affinity Sodium Glucose Cotransporter (SGLT2) Inhibitors, Exhibits Antidiabetic Efficacy in Rodent Models]]></dc:title>
<dc:publisher>American Society for Pharmacology and Experimental Therapeutics</dc:publisher>
</item>

<item rdf:about="http://jpet.aspetjournals.org/cgi/content/short/jpet.108.143271v1?rss=1&amp;ssource=mfc">
<title><![CDATA[Novel Peroxisome Proliferator-Activated Receptor {alpha} Agonists Lower Low-Density Lipoprotein and Triglycerides, Raise High-Density Lipoprotein, and Synergistically Increase Cholesterol Excretion with a Liver X Receptor Agonist]]></title>
<link>http://jpet.aspetjournals.org/cgi/content/short/jpet.108.143271v1?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Ranjan Mukherjee, Kenneth T. Locke, Bowman Miao, Daniel Meyers, Hossain Monshizadegan, Rongan Zhang, Debra Search, Denise Grimm, Michael Flynn, Kevin M. O''Malley, Litao Zhang, Jun Li, Yan Shi, Lawrence J. Kennedy, Michael Blanar, Peter T. Cheng, Joseph Tino, Rai Ajit Srivastava<br />Dec  1, 2008; 327:716-726<br />]]></description>
<dc:creator>Ranjan Mukherjee, Kenneth T. Locke, Bowman Miao, Daniel Meyers, Hossain Monshizadegan, Rongan Zhang, Debra Search, Denise Grimm, Michael Flynn, Kevin M. O''Malley, Litao Zhang, Jun Li, Yan Shi, Lawrence J. Kennedy, Michael Blanar, Peter T. Cheng, Joseph Tino, Rai Ajit Srivastava</dc:creator>
<dc:date>2008-12-01</dc:date>
<dc:title><![CDATA[Novel Peroxisome Proliferator-Activated Receptor {alpha} Agonists Lower Low-Density Lipoprotein and Triglycerides, Raise High-Density Lipoprotein, and Synergistically Increase Cholesterol Excretion with a Liver X Receptor Agonist]]></dc:title>
<dc:publisher>American Society for Pharmacology and Experimental Therapeutics</dc:publisher>
</item>

<item rdf:about="http://jpet.aspetjournals.org/cgi/content/short/321/3/892?rss=1&amp;ssource=mfc">
<title><![CDATA[Histone Deacetylase Inhibitors Exhibit Anti-Inflammatory and Neuroprotective Effects in a Rat Permanent Ischemic Model of Stroke: Multiple Mechanisms of Action]]></title>
<link>http://jpet.aspetjournals.org/cgi/content/short/321/3/892?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Hyeon Ju Kim, Michael Rowe, Ming Ren, Jau-Shyong Hong, Po-See Chen, De-Maw Chuang<br />Jun  1, 2007; 321:892-901<br />]]></description>
<dc:creator>Hyeon Ju Kim, Michael Rowe, Ming Ren, Jau-Shyong Hong, Po-See Chen, De-Maw Chuang</dc:creator>
<dc:date>2007-06-01</dc:date>
<dc:title><![CDATA[Histone Deacetylase Inhibitors Exhibit Anti-Inflammatory and Neuroprotective Effects in a Rat Permanent Ischemic Model of Stroke: Multiple Mechanisms of Action]]></dc:title>
<dc:publisher>American Society for Pharmacology and Experimental Therapeutics</dc:publisher>
</item>

<item rdf:about="http://jpet.aspetjournals.org/cgi/content/short/320/2/535?rss=1&amp;ssource=mfc">
<title><![CDATA[Calorie Restriction Improves Cardiovascular Risk Factors via Reduction of Mitochondrial Reactive Oxygen Species in Type II Diabetic Rats]]></title>
<link>http://jpet.aspetjournals.org/cgi/content/short/320/2/535?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Yukiko Minamiyama, Yasuyuki Bito, Shigekazu Takemura, Yosuke Takahashi, Shintaro Kodai, Shinjiro Mizuguchi, Yuriko Nishikawa, Shigefumi Suehiro, Shigeru Okada<br />Feb  1, 2007; 320:535-543<br />]]></description>
<dc:creator>Yukiko Minamiyama, Yasuyuki Bito, Shigekazu Takemura, Yosuke Takahashi, Shintaro Kodai, Shinjiro Mizuguchi, Yuriko Nishikawa, Shigefumi Suehiro, Shigeru Okada</dc:creator>
<dc:date>2007-02-01</dc:date>
<dc:title><![CDATA[Calorie Restriction Improves Cardiovascular Risk Factors via Reduction of Mitochondrial Reactive Oxygen Species in Type II Diabetic Rats]]></dc:title>
<dc:publisher>American Society for Pharmacology and Experimental Therapeutics</dc:publisher>
</item>

<item rdf:about="http://jpet.aspetjournals.org/cgi/content/short/jpet.108.143719v1?rss=1&amp;ssource=mfc">
<title><![CDATA[A novel and orally active poly (ADP-ribose) polymerase-1 inhibitor, 2-[methoxycarbonyl(4-methoxyphenyl)methyl sulfanyl]-1H-benzimidazole-4-carboxylic acid amide (KR-33889), attenuates injury in in vitro model of cell death and in vivo model of cardiac ischemia]]></title>
<link>http://jpet.aspetjournals.org/cgi/content/short/jpet.108.143719v1?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Kwang-Seok Oh, Sunkyung Lee, Kyu Yang Yi, Ho Won Seo, Hyun-Na Koo, Byung Ho Lee<br />Oct  3, 2008; 0:108143719<br />]]></description>
<dc:creator>Kwang-Seok Oh, Sunkyung Lee, Kyu Yang Yi, Ho Won Seo, Hyun-Na Koo, Byung Ho Lee</dc:creator>
<dc:date>2008-10-03</dc:date>
<dc:title><![CDATA[A novel and orally active poly (ADP-ribose) polymerase-1 inhibitor, 2-[methoxycarbonyl(4-methoxyphenyl)methyl sulfanyl]-1H-benzimidazole-4-carboxylic acid amide (KR-33889), attenuates injury in in vitro model of cell death and in vivo model of cardiac ischemia]]></dc:title>
<dc:publisher>American Society for Pharmacology and Experimental Therapeutics</dc:publisher>
</item>

<item rdf:about="http://jpet.aspetjournals.org/cgi/content/short/299/2/775?rss=1&amp;ssource=mfc">
<title><![CDATA[Biodegradable Nanoparticles for Targeted Drug Delivery in Treatment of Inflammatory Bowel Disease]]></title>
<link>http://jpet.aspetjournals.org/cgi/content/short/299/2/775?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Alf Lamprecht, Nathalie Ubrich, Hiromitsu Yamamoto, Ulrich Schafer, Hirofumi Takeuchi, Philippe Maincent, Yoshiaki Kawashima, Claus-Michael Lehr<br />Nov  1, 2001; 299:775-781<br />INFLAMMATION AND IMMUNOPHARMACOLOGY]]></description>
<dc:creator>Alf Lamprecht, Nathalie Ubrich, Hiromitsu Yamamoto, Ulrich Schafer, Hirofumi Takeuchi, Philippe Maincent, Yoshiaki Kawashima, Claus-Michael Lehr</dc:creator>
<dc:date>2001-11-01</dc:date>
<dc:title><![CDATA[Biodegradable Nanoparticles for Targeted Drug Delivery in Treatment of Inflammatory Bowel Disease]]></dc:title>
<dc:publisher>American Society for Pharmacology and Experimental Therapeutics</dc:publisher>
</item>

<item rdf:about="http://jpet.aspetjournals.org/cgi/content/short/322/3/1013?rss=1&amp;ssource=mfc">
<title><![CDATA[High-Dose Acetaminophen Inhibits the Lethal Effect of Doxorubicin in HepG2 Cells: The Role of P-glycoprotein and Mitogen-Activated Protein Kinase p44/42 Pathway]]></title>
<link>http://jpet.aspetjournals.org/cgi/content/short/322/3/1013?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Irena Manov, Yulia Bashenko, Anat Eliaz-Wolkowicz, Meital Mizrahi, Oded Liran, Theodore C. Iancu<br />Sep  1, 2007; 322:1013-1022<br />CHEMOTHERAPY, ANTIBIOTICS, AND GENE THERAPY]]></description>
<dc:creator>Irena Manov, Yulia Bashenko, Anat Eliaz-Wolkowicz, Meital Mizrahi, Oded Liran, Theodore C. Iancu</dc:creator>
<dc:date>2007-09-01</dc:date>
<dc:title><![CDATA[High-Dose Acetaminophen Inhibits the Lethal Effect of Doxorubicin in HepG2 Cells: The Role of P-glycoprotein and Mitogen-Activated Protein Kinase p44/42 Pathway]]></dc:title>
<dc:publisher>American Society for Pharmacology and Experimental Therapeutics</dc:publisher>
</item>

</rdf:RDF>